Who has been buying UB Care stock?

4 distinct insiders have filed 8 disclosed insider purchases in UB Care (032620), most recently on 2026-06-10. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does UB Care have?

UB Care has 8 buy-side and 0 sell-side disclosures on record, covering ₩371M ($258K) in total reported value, spanning 2025-12-24 to 2026-06-10.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

UB Care 032620

Company

유비케어UB Care

Insiders

Buys

Total Value

₩371M ($258K)

Avg Return

+6.66%

Last Filing

2026-06-10

UB Care (032620) has 8 disclosed insider purchases and 0 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩371M ($258K) in reported transaction value. The earliest filing StockDrifts holds for UB Care is dated 2025-12-24; the most recent is 2026-06-10. Across these filings the average return since disclosure is +6.66%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-06-10	BUY	Market Buy	권태훈 Taehoon Kwon	moving	10.0K	-	-	-
2026-05-20	BUY	Market Buy	백성환 Baek Seong-hwan	moving	6.9K	-	-	-
2026-02-11	BUY	Market Buy	김진태 Jintae Kim	CEO	11.8K	₩4,170	+1.4%	₩49M ($34K)
2026-02-10	BUY	Market Buy	김진태 Jintae Kim	CEO	10.5K	₩4,080	+3.7%	₩43M ($30K)
2026-02-04	BUY	Market Buy	노주현 Noh Joo-hyun	moving	10.0K	₩4,140	+2.2%	₩41M ($29K)
2026-01-14	BUY	Market Buy	권태훈 Taehoon Kwon	moving	10.0K	₩3,805	+11.2%	₩38M ($26K)
2026-01-09	BUY	Market Buy	김진태 Jintae Kim	CEO	14.4K	₩3,925	+7.8%	₩56M ($39K)
2026-01-01	BUY	신규선임	백성환 Baek Seong-hwan	moving	3.3K	₩3,735	+13.3%	₩12M ($9K)
2026-01-01	BUY	신규선임	김준혁 Junhyuk Kim	moving	2.5K	₩3,735	+13.3%	₩9M ($6K)
2025-12-24	BUY	자사주상여금	김진태 Jintae Kim	CEO	26.4K	₩3,720	+13.7%	₩98M ($68K)
2025-12-24	BUY	자사주상여금	노주현 Noh Joo-hyun	moving	2.7K	₩3,720	+13.7%	₩10M ($7K)
2025-12-24	BUY	자사주상여금	권태훈 Taehoon Kwon	moving	2.7K	₩3,720	+13.7%	₩10M ($7K)
2025-12-24	BUY	Market Buy	김진태 Jintae Kim	CEO	38.5K	₩3,720	+13.7%	₩143M ($99K)

Frequently asked questions

Who has been buying UB Care stock?: 4 distinct insiders have filed 8 disclosed insider purchases in UB Care (032620), most recently on 2026-06-10. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does UB Care have?: UB Care has 8 buy-side and 0 sell-side disclosures on record, covering ₩371M ($258K) in total reported value, spanning 2025-12-24 to 2026-06-10.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.